FDA Inspection 1002457 — MP Biomedicals Asia Pacific Pte Ltd
The FDA completed an inspection of MP Biomedicals Asia Pacific Pte Ltd on November 7, 2016 in Singapore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 7, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Singapore (Singapore)